News-Medical.Net on MSN
New ISSCR guidance charts path for pluripotent stem cell therapies
The International Society for Stem Cell Research (ISSCR) today announced the upcoming release of "Charting the Translational ...
The International Society for Stem Cell Research (ISSCR) has released "Charting the Translational Pathway: ISSCR Best Practices for the Development of Pluripotent Stem Cell (PSC)-Derived Therapies," a ...
The International Society for Stem Cell Research (ISSCR) today announced the upcoming release of “Charting the Translational ...
A study by BRIC-RGCB scientists has unveiled new insights into brain development and neural stem cell maintenance, ...
For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...
Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...
In a study published in Cell Research, researchers have identified a fibrous-layer resident subpopulation of P-SSCs labeled ...
“Stem cell therapy and research are still effectively banned in South Africa,” Dr Mia said. “That hasn’t changed in law. What ...
MEDIPOST Inc., a biotechnology company developing allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven degenerative diseases, today announced that its parent company, ...
Hematopoietic stem cells (HSCs) are the cornerstone of lifelong blood formation, arising during embryogenesis from specialised endothelial precursors in a process known as the ...
The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — long-lived cells that help repair and replace damaged tissue in the lungs — ...
The US biomedical funding agency also hints at future restrictions on research involving human embryonic stem cells.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results